ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Accenture and UiPath Join Forces to Help Organizations Accelerate Transformation through Intelligent Automation

Accenture (NYSE: ACN) and UiPath (NYSE: PATH), a leading enterprise automation software company, announced an expanded business collaboration to help companies boost the adoption of enterprise-wide automation, accelerate technology transformation efforts and create new growth opportunities.

As businesses reframe their future in a post-pandemic world, organizations that have been able to scale automation across the enterprise are empowering employees to innovate and drive value in new ways. Initially announced at the UiPath FORWARD IV conference in October, Accenture and UiPath are growing their longstanding alliance to combine robust automation solutions from UiPath with Accenture’s complementary services and industry expertise. This will help clients benefit from intelligent automation to increase productivity as well as create a catalyst for the reinvention of business processes to be more efficient and adaptable to change.

Accenture and UiPath have been jointly serving clients around the world, helping support their automation journeys, including at Uber and the University of Chicago Medical Center.

“At Uber, it’s about how we can apply technology and innovation to serve our customers," said Chad Aronson, global head of Intelligent Automation at Uber. "Partnering with UiPath and Accenture enabled us to take advantage of market-leading automation technology from UiPath and the digital and industry expertise of Accenture. This powerful combination has helped Uber achieve unparalleled results in its digital transformation journey to enhance internal operations productivity, quality, performance and user experience.”

At the University of Chicago Medical Center, the Accenture team has harnessed the power of the UiPath Intelligent Automation platform to drive innovation and improve employee and patient experiences in this time of a global pandemic. In just six months, UChicago Medicine successfully transitioned from a pilot program to a fully operational Bot Center of Excellence that will run, manage and update robotic process automation initiatives.

“Working with Accenture, we have brought automation technology across our supply chain, pharmacy and revenue cycle departments, resulting in cost savings and improvements in both employee and patient experiences. The team is currently exploring and delivering further automation in Epic test automation, IT operational optimization and contact center operations,” said Shariq Ata, executive director for Data Analytics, Architecture, Integration and Innovation at the University of Chicago Medical Center. “Accenture brings the right mix of technical and healthcare expertise to quickly identify, assess and implement UiPath automation solutions.”

“Increased collaboration with UiPath will help our clients realize more benefits from automation and achieve even greater value from the compressed transformations they are making,” said Paul Daugherty, group chief executive – Technology and chief technology officer at Accenture. “When we automate the ordinary, we can unleash the extraordinary. Our expanded work with UiPath marks an important step forward in advancing the business and human potential of automation, combining UiPath’s powerful automation platform with Accenture’s expertise in driving transformational outcomes for its clients.”

“Accenture and UiPath together bring unique capabilities that are unsurpassed, and we believe this will be transformative for clients in every industry,” said Daniel Dines, UiPath co-founder and Chief Executive Officer. “These days, speed goes hand in hand with success. Enterprises can’t afford to wait and hire someone tomorrow to build the solution they need today. Together, UiPath and Accenture can help enterprises realize the full potential of automation at scale as it reaches maturity.”

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 624,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.

About UiPath

UiPath has a vision to deliver the Fully Automated Enterprise™, one where companies use automation to unlock their greatest potential. UiPath offers an end-to-end platform for automation, combining the leading Robotic Process Automation (RPA) solution with a full suite of capabilities that enable every organization to rapidly scale digital business operations.

Copyright © 2021 Accenture. All rights reserved. Accenture and its logo are trademarks of Accenture.

This content is provided for general information purposes and is not intended to be used in place of consultation with our professional advisors. This document refers to marks owned by third parties. All such third-party marks are the property of their respective owners. No sponsorship, endorsement or approval of this content by the owners of such marks is intended, expressed or implied.

@Accenture and @UiPath have joined forces to help organizations accelerate transformation through intelligent #automation

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.50
+1.39 (0.61%)
AAPL  280.69
-0.01 (-0.00%)
AMD  222.99
+7.01 (3.25%)
BAC  54.47
+0.59 (1.09%)
GOOG  322.33
+3.94 (1.24%)
META  668.01
+6.49 (0.98%)
MSFT  481.98
+1.14 (0.24%)
NVDA  183.15
-0.23 (-0.13%)
ORCL  217.71
+3.38 (1.57%)
TSLA  456.20
+1.67 (0.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.